Literature DB >> 11733216

The molecular basis and potential role of survivin in cancer diagnosis and therapy.

D C Altieri1.   

Abstract

Despite its genetic complexity and multifactoriality, two processes appear almost universally compromised in cancer: the control of cell proliferation and the regulation of cell lifespan. Survivin is a recently described molecule that has been implicated in both processes, and is overexpressed in most human cancers. The exploitation of the survivin signaling pathway might provide important predictive and prognostic clues in cancer diagnosis, and offer new therapeutic alternatives for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733216     DOI: 10.1016/s1471-4914(01)02243-2

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  110 in total

1.  Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2.

Authors:  Jian-Guo Qiao; Yu-Qing Zhang; Yu-Chun Yin; Zui Tan
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

Review 2.  Survivin and leukemia.

Authors:  Xiu Li Cong; Zhong Chao Han
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

3.  Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.

Authors:  Xiefeng Wang; Lili Huang; Yanjie Xu; Zhumei Shi; Yingyi Wang; Junxia Zhang; Xirui Wang; Lei Cao; Hui Luo; Jiawei Chen; Ning Liu; Yongmei Yin; Yongping You
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 4.  Early bladder cancer: concept, diagnosis, and management.

Authors:  Hiroshi Kitamura; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

5.  Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.

Authors:  Christine Billecke; Susan Finniss; Laura Tahash; Cathie Miller; Tom Mikkelsen; Nicholas P Farrell; Oliver Bögler
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

6.  Hypothyroidism reduces mammary tumor progression via Β-catenin-activated intrinsic apoptotic pathway in rats.

Authors:  C M López Fontana; L E Zyla; F E Santiano; C V Sasso; F D Cuello-Carrión; V Pistone Creydt; M A Fanelli; R W Carón
Journal:  Histochem Cell Biol       Date:  2017-02-13       Impact factor: 4.304

7.  siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.

Authors:  Wen-Song Liu; Hai-Jiao Yan; Ren-Yi Qin; Rui Tian; Min Wang; Jian-Xin Jiang; Ming Shen; Cheng-Jian Shi
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

8.  Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.

Authors:  Lei Xu; Xin Zhou; Lin Xu; Rong Yin
Journal:  Tumour Biol       Date:  2013-10-05

9.  Expression of survivin and its significance in colorectal cancer.

Authors:  Wei-Chang Chen; Qiang Liu; Jian-Xin Fu; Su-Ya Kang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

10.  Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies.

Authors:  Li-Nian Huang; Dong-Sheng Wang; Yu-Qing Chen; Cheng-Ling Zhao; Bei-Lei Gong; An-Bang Jiang; Wei Jia; Feng-Dan Hu
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.